GL1X · GenesisL1 explorer

MolNFT v1 · #96765 · protein

Crystal structure of human SIRT3 with elt inhibitor 3 [14-(4-{2- [(METHYLSULFONYL)AMINO]ETHYL}PIPERIDIN-1-YL)THIENO[3,2-D]PYRIMIDINE- 6-carboxamide]

4JT9 · NAD-dependent protein deacetylase sirtuin-3, mitochondrial: “Crystal structure of human SIRT3 with elt inhibitor 3 [14-(4-{2…”. X-ray diffraction, 3 ligands (1NS, ZN, NA), 2 pockets (best druggability 0.67). MolNFT v1 #96765 on…

PDB
4JT9
Type
protein
Length
274 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
NAD-dependent protein deacetylase sirtuin-3, mitochondrial
EC
3.5.1.-
UniProt
Q9NTG7
Ligands
1NS, ZN, NA
Pockets
2 · best druggability 0.67

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANAD-dependent protein deacetylase sirtuin-3, mitochondrial (EC 3.5.1.-)protein27441% helix, 17% strandQ9NTG7

Ligands and binding sites

  • 1NS · 4-(4-{2-[(methylsulfonyl)amino]ethyl}piperidin-1-yl)thieno[3,2-d]pyrimidine-6-carboxamide · ligand · chains A
  • ZN · Zinc ion · metal · chains A
  • NA · Sodium ion · metal · chains A
  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14210.670.79441NS, GOL
21140.380.7424empty

Compared structures

  • 4JT9 · Crystal Structure of human SIRT3 with ELT inhibitor 3… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9NTG7 · AlphaFold monomer V2.0 prediction for NAD-dependent protein deacetylase sirtuin-3… · a predicted model of the same protein · chain A against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.